Re:A Government Guide to Keeping Insulin Unaffordable
by pg_bot on Sunday July 07, 2019 @11:21PM
(#20379643)
The older albuterol inhalers are no longer sold because they used CFCs as a propellant. CFC usage was banned internationally by the Montreal protocol in 1987. The propellant could not be immediately replaced due to strict FDA safety guarantees so they carved out a temporary exemption for medical usage. Research and development was done to find a replacement (HFAs) and that work is now being paid for by the patents granted from that process (more expensive inhalers). Whether this was a valid trade-off is a separate discussion but company lobbying is not the reason why they are no longer distributed.
https://www.fda.gov/drugs/questions-answers/transition-cfc-p...
Re:A Government Guide to Keeping Insulin Unaffordable
by tptacek on Monday July 08, 2019 @11:44AM
(#20383687)
I think his point is that evergreening isn't a feature of the patent system; there's no mechanism to extend a patent, and "extension" patents of minor modifications don't extend the legal monopoly on a drug, but rather function as a marketing mechanism that preys on the industry's willingness to prescribe whatever the newest iteration of a drug is, regardless of evidence.
Evergreening is absolutely a thing, and absolutely planned and executed by the companies that profit from it.